Patents by Inventor Vikram M. Bhosale

Vikram M. Bhosale has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of allergic rhinitis using a combination of mometasone and olopatadine
    Patent number: 12064442
    Abstract: The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a pediatric human subject) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.
    Type: Grant
    Filed: June 17, 2022
    Date of Patent: August 20, 2024
    Assignee: GLENMARK SPECIALTY S.A.
    Inventors: Neelima Khairatkar-Joshi, Abhay Kulkarni, Dinesh Pradeep Wale, Vikram M. Bhosale, Piyush Agarwal, Patrick Keohane, Sudeesh K. Tantry, Chad Oh
  • TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADINE
    Publication number: 20240156840
    Abstract: The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a pediatric human subject) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.
    Type: Application
    Filed: December 21, 2023
    Publication date: May 16, 2024
    Inventors: Neelima KHAIRATKAR-JOSHI, Abhay KULKARNI, Dinesh Pradeep WALE, Vikram M. BHOSALE, Piyush AGARWAL, Patrick KEOHANE, Sudeesh K. TANTRY, Chad OH
  • TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADINE
    Publication number: 20220387452
    Abstract: The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a pediatric human subject) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.
    Type: Application
    Filed: June 17, 2022
    Publication date: December 8, 2022
    Inventors: Neelima KHAIRATKAR-JOSHI, Abhay KULKARNI, Dinesh Pradeep WALE, Vikram M. BHOSALE, Piyush AGARWAL, Patrick KEOHANE, Sudeesh K. TANTRY, Chad OH
  • Treatment of allergic rhinitis using a combination of mometasone and olopatadine
    Patent number: 11400101
    Abstract: The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a pediatric human subject) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.
    Type: Grant
    Filed: August 26, 2020
    Date of Patent: August 2, 2022
    Assignee: GLENMARK SPECIALTY S.A.
    Inventors: Neelima Khairatkar-Joshi, Abhay Kulkarni, Dinesh Pradeep Wale, Vikram M. Bhosale, Piyush Agarwal, Patrick Keohane, Sudeesh K. Tantry, Chad Oh
  • TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADINE
    Publication number: 20210077506
    Abstract: The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a pediatric human subject) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.
    Type: Application
    Filed: August 26, 2020
    Publication date: March 18, 2021
    Inventors: Neelima Khairatkar-Joshi, Abhay Kulkarni, Pradeep D. Wale, Vikram M. Bhosale, Piyush Agarwal, Patrick Keohane, Sudeesh K. Tantry, Chad Oh
  • Treatment of allergic rhinitis using a combination of mometasone and olopatadine
    Patent number: 10758550
    Abstract: The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a pediatric human subject) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.
    Type: Grant
    Filed: February 23, 2018
    Date of Patent: September 1, 2020
    Assignee: GLENMARK SPECIALTY S.A.
    Inventors: Neelima Khairatkar-Joshi, Abhay Kulkarni, Pradeep D. Wale, Vikram M. Bhosale, Piyush Agarwal, Patrick Keohane, Sudeesh K. Tantry, Chad Oh
  • Treatment of allergic rhinitis using a combination of mometasone and olopatadine
    Patent number: 10653661
    Abstract: The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a human) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: May 19, 2020
    Assignee: GLENMARK SPECIALTY S.A.
    Inventors: Neelima Khairatkar-Joshi, Abhay Kulkarni, Dinesh Pradeep Wale, Vikram M. Bhosale, Piyush Agarwal, Patrick Keohane, Sudeesh K. Tantry, Chad Oh
  • TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADINE
    Publication number: 20190030047
    Abstract: The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a pediatric human subject) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.
    Type: Application
    Filed: February 23, 2018
    Publication date: January 31, 2019
    Inventors: Neelima Khairatkar-Joshi, Abhay Kulkarni, Pradeep D. Wale, Vikram M. Bhosale, Piyush Agarwal, Patrick Keohane, Sudeesh K. Tantry, Chad Oh
  • TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADINE
    Publication number: 20180369187
    Abstract: The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a human) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.
    Type: Application
    Filed: December 14, 2017
    Publication date: December 27, 2018
    Inventors: Neelima Khairatkar-Joshi, Abhay Kulkarni, Dinesh Pradeep Wale, Vikram M. Bhosale, Piyush Agarwal, Patrick Keohane, Sudeesh K. Tantry, Chad Oh
  • Treatment of allergic rhinitis using a combination of mometasone and olopatadine
    Patent number: 10016443
    Abstract: The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a human) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.
    Type: Grant
    Filed: June 28, 2017
    Date of Patent: July 10, 2018
    Assignee: GLENMARK SPECIALTY S.A.
    Inventors: Neelima Khairatkar-Joshi, Abhay Kulkarni, Pradeep D. Wale, Vikram M. Bhosale, Piyush Agarwal, Patrick Keohane, Sudeesh K. Tantry, Chad Oh
  • TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADINE
    Publication number: 20170333449
    Abstract: The present invention relates to a method of treating allergic rhinitis in a subject (e.g., a human) in need thereof comprising nasally administering to the subject an effective amount of a fixed-dose pharmaceutical composition comprising mometasone or its salt and olopatadine or its salt.
    Type: Application
    Filed: June 28, 2017
    Publication date: November 23, 2017
    Inventors: Neelima KHAIRATKAR-JOSHI, Abhay Kulkami, Pradeep D. Wale, Vikram M. Bhosale, Piyush Agarwal, Patrick Keohane, Sudeesh K. Tantry, Chad Oh